HEALEY ALS Platform Trial - Regimen A Zilucoplan

Investigator: Stanley Appel, MD

Study Coordinator:

Status: Enrolling

ClinicalTrials.gov Number: NCT04436497


Protocol Number: PRO00025613


The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS. Regimen A will evaluate the safety and efficacy of a single study drug, zilucoplan, in participants with ALS.
More to Explore